This page shows the latest Varithena news and features for those working in and with pharma, biotech and healthcare.
Given that BTG's total revenues were £234 in fiscal 2012/13, Varithena's approval looks set to be a transformative event for the company. ... We believe [Varithena] sets a new standard for the treatment of both the symptoms and appearance of varicose
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...